Published in Br J Anaesth on June 27, 2014
Heterologous fibrin sealant derived from snake venom: from bench to bedside - an overview. J Venom Anim Toxins Incl Trop Dis (2017) 0.77
Quality Assessment of Established and Emerging Blood Components for Transfusion. J Blood Transfus (2016) 0.75
Perioperative management of the bleeding patient. Br J Anaesth (2016) 0.75
Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy. Br J Anaesth (2016) 0.75
CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. I. THE CHARACTERIZATION OF THE PROTEIN FRACTIONS OF HUMAN PLASMA. J Clin Invest (1944) 54.40
CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XV. THE PROTEINS CONCERNED IN THE BLOOD COAGULATION MECHANISM. J Clin Invest (1944) 12.79
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood (2008) 4.26
Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol (2013) 4.04
Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care (2013) 3.65
Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol (2004) 3.52
The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg (2013) 3.25
Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology (2006) 3.20
Management of bleeding following major trauma: an updated European guideline. Crit Care (2010) 3.09
Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion (2008) 2.87
Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol (2009) 2.87
Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg (2007) 2.68
HIGH-POTENCY ANTIHAEMOPHILIC FACTOR CONCENTRATE PREPARED FROM CRYOGLOBULIN PRECIPITATE. Nature (1964) 2.68
Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care (2010) 2.47
Management of bleeding following major trauma: a European guideline. Crit Care (2007) 2.40
Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg (2011) 2.39
Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion (2013) 2.30
Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology (2013) 2.08
The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma (2008) 2.07
Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth (2010) 2.01
Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma. J Trauma (2006) 1.96
Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg (2011) 1.77
Blood transfusion and the anaesthetist: management of massive haemorrhage. Anaesthesia (2010) 1.77
The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost (2006) 1.72
Guidelines on the management of massive blood loss. Br J Haematol (2006) 1.72
Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care (2011) 1.66
Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J Am Chem Soc (1946) 1.62
A comparison of methods of pathogen inactivation of FFP. Vox Sang (2011) 1.57
For: Fibrinogen concentrate for management of bleeding. J Thromb Haemost (2011) 1.54
Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost (2012) 1.51
First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology (2011) 1.47
Development of a rapid emergency hemorrhage panel. Transfusion (2010) 1.45
Cryoprecipitate versus commercial fibrinogen concentrate in patients who occasionally require a therapeutic supply of fibrinogen: risk comparison in the case of an emerging transfusion-transmitted infection. Haematologica (2007) 1.44
Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg (2010) 1.35
The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion (1993) 1.34
Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br J Anaesth (2010) 1.30
Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth (2009) 1.24
Adverse effects of plasma transfusion. Transfusion (2012) 1.23
Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. J Cardiothorac Vasc Anesth (2006) 1.20
Fibrinogen replacement therapy: a critical review of the literature. Blood Transfus (2011) 1.17
Transfusion-associated circulatory overload in orthopedic surgery patients: a multi-institutional study. Immunohematology (1996) 1.16
Guidelines on the management of acute myeloid leukaemia in adults. Br J Haematol (2006) 1.15
Transfusion-related acute lung injury (TRALI)--under-diagnosed and under-reported. Br J Anaesth (2003) 1.15
Estimating the cost of blood: past, present, and future directions. Best Pract Res Clin Anaesthesiol (2007) 1.13
A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br J Haematol (2010) 1.10
The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy. Hematology Am Soc Hematol Educ Program (2007) 1.07
Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. Blood (1986) 1.06
The Quebec hemovigilance system: description and results from the first two years. Transfus Apher Sci (2004) 1.05
Cardiac bypass haemostasis: putting blood through the mill. Br J Haematol (1999) 1.02
The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. Int J Obstet Anesth (2010) 1.02
The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model. Transfusion (2010) 1.01
[Coagulation management in trauma-related massive bleeding. - Recommendations of the Task Force for Coagulation (AGPG) of the Austrian Society of Anesthesiology, Resuscitation and Intensive Care Medicine (OGARI)]. Anasthesiol Intensivmed Notfallmed Schmerzther (2010) 0.99
Blood transfusion in cardiac surgery does increase the risk of 5-year mortality: results from a contemporary series of 1714 propensity-matched patients. Transfusion (2013) 0.98
Appropriateness of platelet, fresh frozen plasma and cryoprecipitate transfusion in New South Wales public hospitals. Med J Aust (2003) 0.97
Survival rate changes with transfusion of blood products during liver transplantation. Can J Anaesth (2005) 0.96
Cryoprecipitate: the current state of knowledge. Transfus Med Rev (2009) 0.96
Treatment of classic hemophilia: the use of fibrinogen rich in factor VIII for hemorrhage and for surgery. N Engl J Med (1961) 0.95
Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma. Transfusion (2008) 0.93
Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth (2012) 0.93
Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: a prospective, randomized trial. J Thorac Cardiovasc Surg (2010) 0.93
Transfusing methylene blue-photoinactivated plasma instead of FFP is associated with an increased demand for plasma and cryoprecipitate. Transfusion (2001) 0.91
Use of clotting factors and other prohemostatic drugs for obstetric hemorrhage. Curr Opin Anaesthesiol (2010) 0.91
Instituting a thawed plasma procedure: it just makes sense and saves cents. Transfusion (2009) 0.90
Production of freeze-dried human antihaemophilic cryoprecipitate. J Clin Pathol (1981) 0.88
Cryoprecipitate. Patterns of use. Am J Clin Pathol (2003) 0.87
Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate. Transfusion (2009) 0.87
The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study. Transfus Med (2012) 0.86
Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system. Transfus Med (2009) 0.85
Introduction of fibrinogen in the treatment of hemostatic disorders during orthotopic liver transplantation: implications in the use of allogenic blood. Transplant Proc (2010) 0.84
The role of massive transfusion protocols in obstetrics. Am J Perinatol (2012) 0.84
Cryoprecipitate: an outmoded treatment? Transfus Med (2012) 0.84
Supplementation of fibrinogen in acquired bleeding disorders: experience, evidence, guidelines, and licences. Br J Anaesth (2012) 0.84
Cryoprecipitate use in 25 Canadian hospitals: commonly used outside of the published guidelines. Transfusion (2008) 0.84
Cryoprecipitate use in the PROMMTT study. J Trauma Acute Care Surg (2013) 0.83
Plasma components: FFP, FP24, and thawed plasma. Immunohematology (2007) 0.83
Fibrinogen concentrate substitution therapy for obstetric hemorrhage complicated by coagulopathy. J Obstet Gynaecol Res (2012) 0.83
Fibrinogen concentrate use during major obstetric haemorrhage. Anaesthesia (2010) 0.82
Fibrinogen recovery and changes in fibrin-based clot firmness after cryoprecipitate administration in patients undergoing aortic surgery involving deep hypothermic circulatory arrest. Transfusion (2013) 0.80
Use of fibrin-based thromboelastometry for cryoprecipitate transfusion in cardiac surgery involving deep hypothermic circulatory arrest during cardiopulmonary bypass. Blood Coagul Fibrinolysis (2010) 0.80
Cryoprecipitate transfusion: assessing appropriateness and dosing in trauma. Transfus Med (2011) 0.80
Acquired afibrinogenemia in pregnancy. N Engl J Med (1949) 0.79
Cryoprecipitate: uses and alternatives. Transfus Med Rev (1993) 0.79
Cryoprecipitate for transfusion: which patients receive it and why? A study of patterns of use across three regions in England. Transfus Med (2012) 0.77
Acute anaphylaxis, pulmonary oedema, and intravascular haemolysis due to cryoprecipitate. Arch Dis Child (1973) 0.77
Judith Graham Pool and the discovery of cryoprecipitate. Haemophilia (2012) 0.76
Variability in the fibrinogen and von Willebrand factor content of cryoprecipitate. Implications for reducing donor exposure. Am J Clin Pathol (1990) 0.76
Microwave-thawed plasma for cryoprecipitate production. Vox Sang (1985) 0.76
Preparation of cryoprecipitate from riboflavin and UV light-treated plasma. Transfus Apher Sci (2012) 0.76
Comparison of cryoprecipitate with fibrinogen concentrate for acquired hypofibrinogenaemia. Transfus Apher Sci (2012) 0.76
[Efficacy of cryoprecipitate transfusion for coagulopathy after cardiopulmonary bypass in thoracic aortic surgery]. Masui (2011) 0.76
Restoring hemostasis: fibrinogen concentrate versus cryoprecipitate. Expert Rev Hematol (2013) 0.76
Plasma fibrinogen levels following cryoprecipitate infusion. Transfusion (1971) 0.76
A more potent human antihemophilic globulin concentrate: preparation and clinical trial. Bibl Haematol (1965) 0.76
The usage of blood components in obstetrics. Medicina (Kaunas) (2010) 0.76
Quantitative and qualitative analysis of coagulation factors in cryoprecipitate prepared from fresh-frozen plasma inactivated with amotosalen and ultraviolet A light. Transfusion (2012) 0.76
Cryoprecipitate for the correction of coagulopathy associated with liver disease. Anaesth Intensive Care (2003) 0.76
Intraoperative cryoprecipitate transfusion and its association with the incidence of biliary complications after liver transplantation--a retrospective cohort study. PLoS One (2013) 0.76
Anemia therapy: individual benefit and societal cost. Semin Oncol (1994) 0.75
Incidence of allo-immunization and allergic reactions to cryoprecipitate in haemophilia. Vox Sang (1979) 0.75
Protein composition of clots detected in pooled cryoprecipitate units. Transfusion (2012) 0.75